# C4 Therapeutics, Inc.: Form 8-K, filed May 15, 2026

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: 8-K
- Filed: 2026-05-15
- Accepted by EDGAR: May 15, 2026, 16:03 ET
- Period: 2026-05-15
- Accession: 0001628280-26-035542
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000162828026035542/cccc-20260515.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000162828026035542/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000162828026035542/cccc-20260515.htm

Filed May 15, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-035542. Last ingested by Listed: Nov 5, 2026, 12:02 ET. No prices; not investment advice.